Published on who.int, 26 September 2014 The current evidence base: limited data – from 1976 up to now Convalescent therapy was first used for a young woman infected with Ebola in the Democratic Republic of Congo (then Zaire) in 1976 – the year the virus first emerged. The woman was …
Convalescent blood and plasma therapies Experimental therapies: growing interest in the use of whole blood or plasma from recovered Ebola patients (convalescent therapies) 26 September 2014 WHO interim guidelines on use of convalescent whole blood and convalescent plasma 10 September 2014 Potential vaccines, medicines and other health technologies WHO Meeting …
The Ebola virus keeps spreading in West Africa and some researchers say that a vaccine is necessary to halt the epidemic. The two most advanced candidates have recently entered safety trials, and if they do not cause harm and trigger the immune response scientists hope to see, the World Health …
Ebola en RDC : une nouvelle souche du virus Paris, 15 octobre 2014 Alors qu’une épidémie d’Ebola fait rage depuis mars 2014 en Afrique de l’Ouest, un foyer de cette fièvre hémorragique est apparu en République démocratique du Congo (RDC) au mois d’août dernier, laissant craindre une propagation du virus en …
Key facts Ebola virus disease (EVD), formerly known as Ebola haemorrhagic fever, is a severe, often fatal illness in humans. The virus is transmitted to people from wild animals and spreads in the human population through human-to-human transmission. The average EVD case fatality rate is around 50%. Case fatality …